Cytodyn Inc (CYDY)

[JPG77]

BP will just wait for Mono trial to get over and show efficacy.

Perhaps you're not familiar with the mono trial. It's OPEN LABEL which means the data can be viewed at any time with an NDA. The trial started over 8 months ago and they've already enrolled over a 100 patients, which means by the end of the year, they'll have at a minimum 5 months of data for over a 100 patients for mono.

The mc of the company is so small that a doubling of mc won't matter to BP rather than taking risk by buying the co early.

The timing for making a BO offer isn't based off of the current mc or sp. That's not where the risk is when making a purchase. The timing and price is based off of future revenue potential, and the risk of losing the opportunity to a competitor. The longer they wait, the higher the risk - especially after the PE results for adjunct are announced, which can happen any time.

So, is Fred off today?